Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the Trump administration’s policies on pricing and tariffs.
www.marketwatch.com
#Pfizer #onceamonth #weightloss #drug #works #forecasts #profit #decline
Pfizer says once-a-month weight-loss drug works as it forecasts profit decline
